Borgel Delphine, Vieillard-Baron Antoine
AP-HP, Service d'Hématologie et d'Immunologie, Hôpital Ambroise Paré, 9 av Charles de Gaulle, 92100 Boulogne Billancourt - EA4531, Faculté de Pharmacie, Université Paris-Sud, 5 rue Jean-Baptiste Clément, 92296 Chatenay-Malabry, France.
Med Sci (Paris). 2011 May;27(5):501-7. doi: 10.1051/medsci/2011275015. Epub 2011 May 25.
Sepsis is defined as a systemic response to infection, characterized by an intense inflammatory response linked to coagulation activation and fibrinolysis inhibition, two processes which are intimately associated. In a field where mortality remains very high, administration of activated protein C, a physiological coagulation inhibitor with cytoprotective properties, has demonstrated its effectiveness and was able to reduce mortality. Protein C belongs to a system that involves plasma proteins and endothelial cell receptors. In addition to well documented effects on coagulation and fibrinolysis, activated protein C exhibits anti-inflammatory, anti-apoptotic but also anti-histone activities. Indeed, a recent study focusing on the cytoprotective effects of activated protein C showed that extracellular histones are released during severe sepsis and may participate in the pathophysiology of severe sepsis. These histones appear to be new targets of activated protein C.
脓毒症被定义为对感染的全身性反应,其特征是与凝血激活和纤溶抑制相关的强烈炎症反应,这两个过程密切相关。在一个死亡率仍然很高的领域,给予活化蛋白C(一种具有细胞保护特性的生理性凝血抑制剂)已证明其有效性,并能够降低死亡率。蛋白C属于一个涉及血浆蛋白和内皮细胞受体的系统。除了对凝血和纤溶有充分记录的作用外,活化蛋白C还具有抗炎、抗凋亡以及抗组蛋白活性。事实上,最近一项关注活化蛋白C细胞保护作用的研究表明,细胞外组蛋白在严重脓毒症期间释放,并可能参与严重脓毒症的病理生理学过程。这些组蛋白似乎是活化蛋白C的新靶点。